[1]
Rasmussen NH, Dal J, den Bergh JV, de Vries F, Jensen MH, Vestergaard P. Increased risk of falls, fall-related injuries and fractures in people with type 1 and type 2 diabetes - a nationwide cohort study. Curr Drug Saf 2021; 6(1): 52-61.
[http://dx.doi.org/10.2174/1574886315666200908110058] [PMID: 32900349]
[http://dx.doi.org/10.2174/1574886315666200908110058] [PMID: 32900349]
[2]
Nissen TPH, Vorum H, Aasbjerg K. Biologic therapy and treatment options in diabetic retinopathy with diabetic macular edema. Curr Drug Saf 2021; 6(1): 17-31.
[http://dx.doi.org/0.2174/1574886315666200902154322] [PMID: 32881673]
[http://dx.doi.org/0.2174/1574886315666200902154322] [PMID: 32881673]
[3]
Røikjer J, Mørch CD, Ejskjaer N. Diabetic peripheral neuropathy: Diagnosis and treatment. Curr Drug Saf 2021; 6(1): 2-16.
[http://dx.doi.org/10.2174/1574886315666200731173113] [PMID: 32735526]
[http://dx.doi.org/10.2174/1574886315666200731173113] [PMID: 32735526]
[4]
Pietraszek A. Cardiovascular Effects of hypoglycemic agents in diabetes mellitus. Curr Drug Saf 2021; 6(1): 32-51.
[http://dx.doi.org/10.2174/1574886315666200902154736] [PMID: 32881674]
[http://dx.doi.org/10.2174/1574886315666200902154736] [PMID: 32881674]
[5]
Laursen HVB, Røikjer JB, Dal J, Jensen MH. Sodium glucose cotransporter-2 inhibitor treatment and the risk of diabetic ketoacidosis in Denmark: A retrospective cohort study of five years of use. Curr Drug Saf 2021; 6(1): 73-81.
[http://dx.doi.org/10.2174/1574886315666200819114629] [PMID: 32814538]
[http://dx.doi.org/10.2174/1574886315666200819114629] [PMID: 32814538]
[6]
Werkman NCC, Nielen JTH, van den Bergh JPW, et al. Use of Sodium-Glucose Co-Transporter-2-Inhibitors (SGLT2-Is) and risk of lower limb amputation. Curr Drug Saf 2021; 6(1): 62-72.
[http://dx.doi.org/10.2174/1574886315666200805103053] [PMID: 32767909]
[http://dx.doi.org/10.2174/1574886315666200805103053] [PMID: 32767909]
Current Drug Safety
Title:Diabetes and its Complications - Contemporary Treatment and Potential Side Effects of Drugs to Treat Diabetes
Volume: 16 Issue: 1
Author(s): Peter Vestergaard*
Affiliation:
- Head of Research, Steno Diabetes Center North Jutland, Aalborg and Department of Clinical Medicine Aalborg University Hospital Aalborg,Denmark
Export Options
About this article
Cite this article as:
Vestergaard Peter *, Diabetes and its Complications - Contemporary Treatment and Potential Side Effects of Drugs to Treat Diabetes, Current Drug Safety 2021; 16 (1) . https://dx.doi.org/10.2174/157488631601210203093615
DOI https://dx.doi.org/10.2174/157488631601210203093615 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
19
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Schizoaffective Disorders in the Elderly
Current Drug Safety Intracerebral Hemorrhage and Diabetes Mellitus: Blood-Brain Barrier Disruption, Pathophysiology and Cognitive Impairments
CNS & Neurological Disorders - Drug Targets Effect of Fasting Ramadan in Diabetes Control Status - Application of Extensive Diabetes Education, Serum Creatinine with HbA1c Statistical ANOVA and Regression Models to Prevent Hypoglycemia
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) MR Imaging of Pancreatic Islets: Tracking Isolation, Transplantation and Function
Current Pharmaceutical Design Design of Bioartificial Pancreas with Functional Micro/Nano-Based Encapsulation of Islets
Current Pharmaceutical Biotechnology Type 2 Diabetes and Obesity in Children and Adolescents: Experience from Studies in Taiwanese Population
Current Diabetes Reviews Diabetes Gene Therapy: Potential and Challenges
Current Gene Therapy Clinical and Forensic Signs Related to Opioids Abuse
Current Drug Abuse Reviews Progress in the Diagnosis and Treatment of Pulmonary Aspergillosis
Current Respiratory Medicine Reviews Methylglyoxal, A Metabolite Increased in Diabetes is Associated with Insulin Resistance, Vascular Dysfunction and Neuropathies
Current Drug Metabolism An Approach to Diabetic Ketoacidosis in an Emergency Setting
Reviews on Recent Clinical Trials Hyperglycemic Hyperosmolar State: A Pragmatic Approach to Properly Manage Sodium Derangements
Current Diabetes Reviews Side Effects of Atypical Antipsychotic Drugs
Current Pharmaceutical Design The Interactions Between Diabetes Mellitus and Myelodysplastic Syndromes: Current State of Evidence and Future Directions
Current Diabetes Reviews Pharmacology and Chemistry of Diabetes mellitus and Antidiabetic Drugs: A Critical Review
Current Medicinal Chemistry Impact of Glycemic Variability and Hypoglycemia on the Mortality and Length of Hospital Stay among Elderly Patients in Brazil
Current Diabetes Reviews Estrogen and Serotonin: Complexity of Interactions and Implications for Epileptic Seizures and Epileptogenesis
Current Neuropharmacology Equilibrative Nucleoside Transporters in Fetal Endothelial Dysfunction in Diabetes Mellitus and Hyperglycaemia
Current Vascular Pharmacology Schizophrenia: Causes and Treatments
Current Pharmaceutical Design An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
Current Drug Therapy